Results 321 to 330 of about 1,869,874 (388)
Objectives Dotinurad is a selective urate reabsorption inhibitor that reduces serum urate levels. We compared the efficacy and safety of dotinurad with febuxostat in Chinese patients with gout. Methods This phase 3, multicentre, randomised, double‐blind, parallel‐group study randomly allocated (1:1) eligible patients with gout to receive oral dotinurad
Jia Sun+19 more
wiley +1 more source
The association of high body mass index with the safety and efficacy of sacituzumab govitecan in patients with metastatic triple-negative breast cancer from the ASCENT study. [PDF]
García-Estévez L+15 more
europepmc +1 more source
Objective Abnormalities in pain regulatory mechanisms are common in patients with rheumatoid arthritis (RA). We investigated whether pain sensitization changes after treatment with a disease modifying anti‐rheumatic drug (DMARD) and explored associations between changes in pain sensitization and disease activity.
Burcu Aydemir+10 more
wiley +1 more source
Global burden and epidemic trends of chronic kidney disease attributable to high body mass index: insights from the Global Burden of Disease Study 2021. [PDF]
Rao Z, Wang K, Zhou K, Duan Y, Zhang Y.
europepmc +1 more source
Objective Despite availability of biologics and targeted synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) to treat rheumatoid arthritis (RA), many patients do not experience optimized disease control. Glucocorticoids are effective but have safety risks.
Frank Buttgereit+13 more
wiley +1 more source
Association of height, BMI, and smoking status with prostate cancer risk before and after the introduction of PSA testing in Sweden. [PDF]
Mboya IB+16 more
europepmc +1 more source
BMI IS PREDICTIVE OF DECREASING HYPOGLYCEMIC AGENTS DURING CARDIAC REHABILITATION
Tomáš Klinger+3 more
openalex +1 more source
Widespread Skin Telangiectasias in Spinocerebellar Ataxia Type 27B
Annals of Neurology, EarlyView.
Victor Alm+3 more
wiley +1 more source
Objectives The effect of the shared epitope (SE), and valine at position 11 (Val11) of HLA‐DRB1, on the activation of CD4+ T cells, is expected to be diminished by abatacept, a co‐stimulation blocker. However, published evidence on the value of genetic stratification for abatacept treatment is conflicting.
Chuan Fu Yap+14 more
wiley +1 more source